Maxime Vigier

ORCID: 0000-0001-9719-1402
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sphingolipid Metabolism and Signaling
  • Cholesterol and Lipid Metabolism
  • Peroxisome Proliferator-Activated Receptors
  • Pancreatic function and diabetes
  • Lipid Membrane Structure and Behavior
  • Alzheimer's disease research and treatments
  • Cellular transport and secretion
  • Retinal Development and Disorders

Laboratoire Animal et Agroécosystèmes
2020-2024

Université de Lorraine
2022-2024

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
2024

Docosahexaenoic acid (DHA, C22:6 ω3) may be involved in various neuroprotective mechanisms that could prevent Alzheimer's disease (AD). Its influence has still been little explored regarding the dysfunction of endolysosomal pathway, known as an early key event physiopathological continuum triggering AD. This result from accumulation degradation products precursor protein AD, particular C99 fragment, capable interacting with endosomal proteins and thus contributing to altering this pathway...

10.3390/ijms25136816 article EN International Journal of Molecular Sciences 2024-06-21

Perturbations of cholesterol metabolism have been linked to neurodegenerative diseases. Glia-neuron crosstalk is essential achieve a tight regulation brain trafficking. Adequate supply from glia via apolipoprotein E-containing lipoproteins ensures neuronal development and function. The lipolysis-stimulated lipoprotein receptor (LSR), plays an important role in homeostasis. Aged heterozygote Lsr+/- mice show altered distribution increased susceptibility amyloid stress. Since LSR expression...

10.3390/ijms23042049 article EN International Journal of Molecular Sciences 2022-02-12
Coming Soon ...